Sectors

BCAB
BioAtla, Inc.
1.74
2 x 1.51
2 x 2.21
bid
ask
+
0.00
0.00%
2 @ 07:59 PM
1.76 +0.02 (1.44%)
Ytd-93.89%
1y-91.74%
1.51
day range
2.10
1.51
52 week range
71.50
Open1.58Prev Close1.74Low1.51High2.10Mkt Cap2.89M
Vol1.03MAvg Vol79.60KEPS-25.07P/EN/AForward P/E-0.42
Beta1.02Short Ratio3.70Inst. Own42.79%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning11-1250-d Avg3.53200-d Avg12.791yr Est9.00
Income Statement
Total Revenue6.50M
Revenues (USD)6.50M
Gross Profit6.50M
Operating Expenses6.27M
Research and Development Expense3.34M
Selling, General and Administrative Expense2.93M
Operating Income227.00K
Net Income452.00K
Net Income Common Stock452.00K
Net Income Common Stock (USD)452.00K
Consolidated Income452.00K
Earnings per Basic Share0.27
Earnings per Basic Share (USD)0.27
Earnings per Diluted Share0.27
Earning Before Interest & Taxes (EBIT)452.00K
Earning Before Interest & Taxes (USD)452.00K
Weighted Average Shares1.66M
Weighted Average Shares Diluted1.66M
Balance Sheet
Cash and Equivalents1.54M
Cash and Equivalents (USD)1.54M
Trade and Non-Trade Receivables2.00M
Current Assets4.26M
Property, Plant & Equipment Net5.09M
Total Assets9.51M
Debt Current1.57M
Total Debt5.86M
Current Liabilities21.02M
Debt Non-Current4.29M
Total Liabilities45.74M
Accumulated Retained Earnings (Deficit)-551.54M
Shareholders Equity-36.24M
Shareholders Equity (USD)-36.24M
Assets Non-Current5.25M
Total Debt (USD)5.86M
Liabilities Non-Current24.72M
Trade and Non-Trade Payables19.45M
Cash Flow
Net Cash Flow from Financing2.00K
Net Cash Flow / Change in Cash & Cash Equivalents-417.00K
Issuance (Purchase) of Equity Shares3.00K
Net Cash Flow from Operations-419.00K
Share Based Compensation619.00K